Renata Walewska

7PUBLICATIONS
65CO-AUTHORS
Disease surveillanceGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 17, 2026
Trends and socio-economic disparities in chronic lymphocytic leukaemia 2014-2022: An England-wide cohort study from the UNCOVER group.

|May 27, 2026
Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

|Apr 29, 2026
Acalabrutinib monotherapy as a first-line treatment for CLL: 3-year follow-up of the real-world EPIC study.

|Oct 10, 2025
2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia.

R Walewska, T A Eyre, A Bloor

|Jul 11, 2025
Physical Activity, Symptoms, Quality of Life and Exercise Program Preferences in People With Chronic Lymphocytic Leukaemia.

Ellie E Miles, Jennifer L Nicol, Hatti Fowler

|Sep 10, 2024
Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials.

Louise Carr, Kevin Norris, Helen Parker

Pageof 2

Frequent Collaborators

3 joint publications

Toby A Eyre

3 joint publications

Nicolás Martínez-Calle

3 joint publications

Andrew Pettitt

2 joint publications

Francesco Forconi